PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11939482-6 2002 Taurine led to an increased release of MPO and concomitant significantly reduced O2- and H2O2 levels. Taurine 0-7 myeloperoxidase Homo sapiens 39-42 11939482-8 2002 In the case of MPO, taurine neutralized propofol"s effects, supporting the idea that MPO activity may be regulated by taurine. Taurine 20-27 myeloperoxidase Homo sapiens 85-88 11939482-8 2002 In the case of MPO, taurine neutralized propofol"s effects, supporting the idea that MPO activity may be regulated by taurine. Taurine 118-125 myeloperoxidase Homo sapiens 85-88 11301057-4 2001 In contrast, most of them induced a dose-dependent inhibition of the taurine chlorination mediated by a myeloperoxidase/H2O2/Cl- system. Taurine 69-76 myeloperoxidase Homo sapiens 104-119 11096071-12 2001 Moreover, human neutrophils used myeloperoxidase, H2O2, and Br(-) to brominate deoxycytidine by a taurine-sensitive pathway, suggesting that transhalogenation reactions may be physiologically relevant. Taurine 98-105 myeloperoxidase Homo sapiens 33-48 11096071-10 2001 Moreover, taurine inhibited 5-bromodeoxycytidine production by the myeloperoxidase-H2O2-Cl(-)- Br(-) system but not by the eosinophil peroxidase-H2O2-Cl(-)-Br(-) system, indicating that bromination by myeloperoxidase involves the initial production of HOCl. Taurine 10-17 myeloperoxidase Homo sapiens 67-82 11096071-10 2001 Moreover, taurine inhibited 5-bromodeoxycytidine production by the myeloperoxidase-H2O2-Cl(-)- Br(-) system but not by the eosinophil peroxidase-H2O2-Cl(-)-Br(-) system, indicating that bromination by myeloperoxidase involves the initial production of HOCl. Taurine 10-17 myeloperoxidase Homo sapiens 201-216 10994875-3 2000 Myeloperoxidase-mediated apoptosis induction is inhibited by SOD, catalase, 4-aminobenzoyl hydrazide, taurine and DMSO. Taurine 102-109 myeloperoxidase Homo sapiens 0-15 11004581-5 2000 The efficiency of MPO inhibitors to prevent LDL damage increased in the series benzohydroxamic acid < salicylhydroxamic acid < 3-amino-1,2,4-triazole < sodium azide < potassium cyanide < p-hydroxy-benzoic acid hydrazide, while for the HOCl traps the protective efficiency increased in the series glycine < taurine < methionine. Taurine 324-331 myeloperoxidase Homo sapiens 18-21 11258981-6 2001 The myeloperoxidase-catalyzed reaction with 0.3 mM NO(2)(-) was completely inhibited by 1 mM cyanide, and not effected by 100 mM chloride with or without 1 mM taurine. Taurine 159-166 myeloperoxidase Homo sapiens 4-19 10733879-8 2000 The activities of the two myeloperoxidase samples, as measured using either the tetramethylbenzidine or the taurine chloramine assay, were indistinguishable. Taurine 108-115 myeloperoxidase Homo sapiens 26-41 2540500-5 1989 The MPO + H2O2 system, which generated more pronounced LCL than either component alone, was inhibited by catalase and taurine but not by SOD. Taurine 118-125 myeloperoxidase Homo sapiens 4-7 9635031-0 1998 Myeloperoxidase (MPO) may mediate neutrophil adherence to the endothelium through upregulation of CD11B expression--an effect downregulated by taurine. Taurine 143-150 myeloperoxidase Homo sapiens 0-15 9635031-0 1998 Myeloperoxidase (MPO) may mediate neutrophil adherence to the endothelium through upregulation of CD11B expression--an effect downregulated by taurine. Taurine 143-150 myeloperoxidase Homo sapiens 17-20 9034238-7 1997 The formation of 3-chloro PABA was inhibited by azide, catalase, and taurine, which is consistent with the production of the metabolite by the neutrophil myeloperoxidase (MPO) pathway. Taurine 69-76 myeloperoxidase Homo sapiens 154-169 9034238-7 1997 The formation of 3-chloro PABA was inhibited by azide, catalase, and taurine, which is consistent with the production of the metabolite by the neutrophil myeloperoxidase (MPO) pathway. Taurine 69-76 myeloperoxidase Homo sapiens 171-174 8132515-0 1994 Chlorination of taurine by myeloperoxidase. Taurine 16-23 myeloperoxidase Homo sapiens 27-42 8132515-2 1994 The chlorination of taurine by the myeloperoxidase-H2O2-Cl- system was investigated under steady state conditions. Taurine 20-27 myeloperoxidase Homo sapiens 35-50 8132515-11 1994 The fast formation of taurine monochloramine, a relatively non-toxic and stable compound compared to HOCl, is consistent with the proposed role of taurine in the neutrophil, that of protecting certain targets including myeloperoxidase from the attack by potent chlorinated oxidants. Taurine 22-29 myeloperoxidase Homo sapiens 219-234 1337841-3 1992 It is suggested that therapeutic effect of new Russian eye drops taufon and sevitin is due to neutralization of the reaction product hypochlorite anion catalyzed by myeloperoxidase. Taurine 65-71 myeloperoxidase Homo sapiens 165-180 1316115-4 1992 Degradation of MeHg and EtHg with the myeloperoxidase (MPO)-H2O2-chloride system was inhibited by MPO inhibitors (cyanide and azide), catalase, hypochlorous acid (HOCI) scavengers (glycine, alanine, serine and taurine), 1,4-diazabicyclo[2,2,2]octane and 2,5-dimethylfuran, but not by hydroxyl radical scavengers (ethanol and mannitol). Taurine 210-217 myeloperoxidase Homo sapiens 38-53 1316115-4 1992 Degradation of MeHg and EtHg with the myeloperoxidase (MPO)-H2O2-chloride system was inhibited by MPO inhibitors (cyanide and azide), catalase, hypochlorous acid (HOCI) scavengers (glycine, alanine, serine and taurine), 1,4-diazabicyclo[2,2,2]octane and 2,5-dimethylfuran, but not by hydroxyl radical scavengers (ethanol and mannitol). Taurine 210-217 myeloperoxidase Homo sapiens 55-58 1316115-4 1992 Degradation of MeHg and EtHg with the myeloperoxidase (MPO)-H2O2-chloride system was inhibited by MPO inhibitors (cyanide and azide), catalase, hypochlorous acid (HOCI) scavengers (glycine, alanine, serine and taurine), 1,4-diazabicyclo[2,2,2]octane and 2,5-dimethylfuran, but not by hydroxyl radical scavengers (ethanol and mannitol). Taurine 210-217 myeloperoxidase Homo sapiens 98-101 2343183-5 1990 The addition of azide, CuDIPS, or taurine markedly inhibited the induction of SCEs by the combination of BP-7,8-diol and stimulated PMNs, further suggesting the involvement of myeloperoxidase in the activation of the polycyclic aromatic hydrocarbon. Taurine 34-41 myeloperoxidase Homo sapiens 176-191 2562426-7 1989 In the presence of taurine (1 or 10 mM), a scavenger of hypohalous acids, MPO/H2O2 catalysis of oxidative cleavage was unaffected with Br-, prevented with Cl-, and partially prevented with Cl- + Br-. Taurine 19-26 myeloperoxidase Homo sapiens 74-77 2991128-4 1985 As the MPO-H2O2-Cl- system is capable of generating the powerful oxidant hypochlorous acid (HOCl), cytotoxicity assays were performed in the presence of taurine, glycine, serine and valine to scavenge this potentially lytic agent. Taurine 153-160 myeloperoxidase Homo sapiens 7-10 3040589-2 1987 Results from experiments in which catalase, taurine, mannitol, or glucose-glucose oxidase were added to these phagocytes indicated that the MPO-hydrogen peroxide-halide system and an MPO-independent oxidative system exerted comparable conidiacidal activity. Taurine 44-51 myeloperoxidase Homo sapiens 140-143 3040589-2 1987 Results from experiments in which catalase, taurine, mannitol, or glucose-glucose oxidase were added to these phagocytes indicated that the MPO-hydrogen peroxide-halide system and an MPO-independent oxidative system exerted comparable conidiacidal activity. Taurine 44-51 myeloperoxidase Homo sapiens 183-186 3032796-9 1987 MPO bound to the high-avidity sites did not oxidize guaiacol but oxidized chloride, as detected by the chlorination of taurine. Taurine 119-126 myeloperoxidase Homo sapiens 0-3 6095920-5 1984 Taurine, which in the presence of myeloperoxidase-H2O2-Cl forms hydrophilic chloramines, and D-penicillamine, which scavenges HOCl, neutralize the inhibitory effect of myeloperoxidase. Taurine 0-7 myeloperoxidase Homo sapiens 34-49 6095920-5 1984 Taurine, which in the presence of myeloperoxidase-H2O2-Cl forms hydrophilic chloramines, and D-penicillamine, which scavenges HOCl, neutralize the inhibitory effect of myeloperoxidase. Taurine 0-7 myeloperoxidase Homo sapiens 168-183 6286728-2 1982 The model hydrogen peroxide-myeloperoxidase-chloride system is capable of generating the powerful oxidant hypochlorous acid, which can be quantitated by trapping the generated species with the beta-amino acid, taurine. Taurine 210-217 myeloperoxidase Homo sapiens 28-43 6882917-5 1983 Thus, taurine chloramine generation by human monocytes appeared dependent on both H2O2 and myeloperoxidase. Taurine 6-13 myeloperoxidase Homo sapiens 82-106 6286728-12 1982 Based on the demonstrated ability of the myeloperoxidase system to generate free hypochlorous acid we conclude that neutrophils chlorinate taurine by producing this powerful oxidant. Taurine 139-146 myeloperoxidase Homo sapiens 41-56 6286728-4 1982 Using this system, purified myeloperoxidase in the presence of chloride and taurine converted stoichiometric quantities of hydrogen peroxide to taurine chloramine. Taurine 76-83 myeloperoxidase Homo sapiens 28-43 29496995-3 2018 This work demonstrates that the heme protein myeloperoxidase (MPO), which is secreted at high concentrations at inflammatory sites from stimulated neutrophils and monocytes, is able to catalyze the two-electron oxidation of cyanide to cyanate and promote the carbamylation of taurine, lysine, and low-density lipoproteins. Taurine 276-283 myeloperoxidase Homo sapiens 45-60 32865666-0 2020 Taurine chloramine selectively regulates neutrophil degranulation through the inhibition of myeloperoxidase and upregulation of lactoferrin. Taurine 0-7 myeloperoxidase Homo sapiens 92-107 32865666-2 2020 Upon neutrophil activation, taurine reacts with hypochlorous acid (HOCl/OCl-) produced by the myeloperoxidase (MPO) system and gets converted to taurine chloramine (Tau-Cl). Taurine 28-35 myeloperoxidase Homo sapiens 94-109 32865666-2 2020 Upon neutrophil activation, taurine reacts with hypochlorous acid (HOCl/OCl-) produced by the myeloperoxidase (MPO) system and gets converted to taurine chloramine (Tau-Cl). Taurine 28-35 myeloperoxidase Homo sapiens 111-114 32865666-2 2020 Upon neutrophil activation, taurine reacts with hypochlorous acid (HOCl/OCl-) produced by the myeloperoxidase (MPO) system and gets converted to taurine chloramine (Tau-Cl). Taurine 145-152 myeloperoxidase Homo sapiens 94-109 32865666-2 2020 Upon neutrophil activation, taurine reacts with hypochlorous acid (HOCl/OCl-) produced by the myeloperoxidase (MPO) system and gets converted to taurine chloramine (Tau-Cl). Taurine 145-152 myeloperoxidase Homo sapiens 111-114 200271-0 1977 Myeloperoxidase inactivation in the course of catalysis of chlorination of taurine. Taurine 75-82 myeloperoxidase Homo sapiens 0-15 200271-2 1977 In the presence of H2O2 and Cl- at pH 4.0-6.6 the myeloperoxidase catalyses chlorination of taurine to monochloramine taurine and simultaneously undergoes inactivation. Taurine 92-99 myeloperoxidase Homo sapiens 50-65 33586039-0 2021 Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women. Taurine 0-7 myeloperoxidase Homo sapiens 32-47 29496995-3 2018 This work demonstrates that the heme protein myeloperoxidase (MPO), which is secreted at high concentrations at inflammatory sites from stimulated neutrophils and monocytes, is able to catalyze the two-electron oxidation of cyanide to cyanate and promote the carbamylation of taurine, lysine, and low-density lipoproteins. Taurine 276-283 myeloperoxidase Homo sapiens 62-65 28971841-0 2017 Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine. Taurine 78-85 myeloperoxidase Homo sapiens 8-23 28971841-5 2017 Oral administration of taurine [1% or 4% (wt/vol) in drinking water], an amino acid known to react rapidly with MPO-generated oxidants like hypochlorous acid, also prevented AAA formation in the ANG II and elastase models as well as the CaCl2 application model of AAA formation while reducing aortic peroxidase activity and aortic protein-bound dityrosine levels, an oxidative cross link formed by MPO. Taurine 23-30 myeloperoxidase Homo sapiens 112-115 28971841-5 2017 Oral administration of taurine [1% or 4% (wt/vol) in drinking water], an amino acid known to react rapidly with MPO-generated oxidants like hypochlorous acid, also prevented AAA formation in the ANG II and elastase models as well as the CaCl2 application model of AAA formation while reducing aortic peroxidase activity and aortic protein-bound dityrosine levels, an oxidative cross link formed by MPO. Taurine 23-30 myeloperoxidase Homo sapiens 398-401 28971841-8 2017 These data implicate MPO in AAA pathogenesis and suggest that studies exploring whether taurine can serve as a potential therapeutic for the prevention or treatment of AAA in patients merit consideration.NEW & NOTEWORTHY Neutrophils are abundant in abdominal aortic aneurysm (AAA), and myeloperoxidase (MPO), prominently expressed in neutrophils, is associated with AAA in humans. Taurine 88-95 myeloperoxidase Homo sapiens 290-305 28971841-8 2017 These data implicate MPO in AAA pathogenesis and suggest that studies exploring whether taurine can serve as a potential therapeutic for the prevention or treatment of AAA in patients merit consideration.NEW & NOTEWORTHY Neutrophils are abundant in abdominal aortic aneurysm (AAA), and myeloperoxidase (MPO), prominently expressed in neutrophils, is associated with AAA in humans. Taurine 88-95 myeloperoxidase Homo sapiens 307-310 28971841-9 2017 This study demonstrates that MPO gene deletion or supplementation with the natural product taurine, which can scavenge MPO-generated oxidants, can prevent AAA formation, suggesting an attractive potential therapeutic strategy for AAA. Taurine 91-98 myeloperoxidase Homo sapiens 29-32 28971841-9 2017 This study demonstrates that MPO gene deletion or supplementation with the natural product taurine, which can scavenge MPO-generated oxidants, can prevent AAA formation, suggesting an attractive potential therapeutic strategy for AAA. Taurine 91-98 myeloperoxidase Homo sapiens 119-122 22810731-5 2014 Indeed, at the site of inflammation, taurine is known to react with and detoxify hypochlorous acid generated by the neutrophil myeloperoxidase (MPO)-halide system. Taurine 37-44 myeloperoxidase Homo sapiens 127-142 25790937-9 2015 The inhibition of taurine N-chloramine production by neutrophils and HL-60 cells in the presence of MPO-affecting substances is demonstrated. Taurine 18-25 myeloperoxidase Homo sapiens 100-103 24412858-11 2014 Taurine sequesters HOCl from myeloperoxidase of activated leukocytes, and taurine supplementation reduced renal lipid oxidation, reduced leukocyte infiltration, and reduced the increase in myeloperoxidase-positive cells during ethanol feeding. Taurine 0-7 myeloperoxidase Homo sapiens 29-44 24412858-11 2014 Taurine sequesters HOCl from myeloperoxidase of activated leukocytes, and taurine supplementation reduced renal lipid oxidation, reduced leukocyte infiltration, and reduced the increase in myeloperoxidase-positive cells during ethanol feeding. Taurine 0-7 myeloperoxidase Homo sapiens 189-204 24412858-11 2014 Taurine sequesters HOCl from myeloperoxidase of activated leukocytes, and taurine supplementation reduced renal lipid oxidation, reduced leukocyte infiltration, and reduced the increase in myeloperoxidase-positive cells during ethanol feeding. Taurine 74-81 myeloperoxidase Homo sapiens 189-204 24412858-12 2014 Taurine supplementation also normalized circulating BUN and creatinine levels and suppressed enhanced myeloperoxidase, albumin, KIM-1, and cystatin c in urine. Taurine 0-7 myeloperoxidase Homo sapiens 102-117 22810731-5 2014 Indeed, at the site of inflammation, taurine is known to react with and detoxify hypochlorous acid generated by the neutrophil myeloperoxidase (MPO)-halide system. Taurine 37-44 myeloperoxidase Homo sapiens 144-147 22810731-9 2014 This review summarizes our current knowledge concerning the role of taurine, TauCl and TauBr in the pathogenesis of inflammatory diseases initiated or propagated by MPO-derived oxidants. Taurine 68-75 myeloperoxidase Homo sapiens 165-168 22810731-10 2014 The aim of this paper is to show links between inflammation, neutrophils, MPO, oxidative stress and taurine. Taurine 100-107 myeloperoxidase Homo sapiens 74-77 22039673-1 2011 Taurine chloramine (TauCl) is generated at the site of inflammation as a result of reaction of taurine with hypochlorous acid (HOCl), the product of myeloperoxidase-halide system of neutrophils. Taurine 95-102 myeloperoxidase Homo sapiens 149-164 23581551-4 2013 Via structure-based drug design, a new series of MPO inhibitors derived from 3-alkylindole were synthesized and their effects were assessed on MPO-mediated taurine chlorination and low-density lipoprotein oxidation as well as on inhibition of SERT. Taurine 156-163 myeloperoxidase Homo sapiens 49-52 23581551-4 2013 Via structure-based drug design, a new series of MPO inhibitors derived from 3-alkylindole were synthesized and their effects were assessed on MPO-mediated taurine chlorination and low-density lipoprotein oxidation as well as on inhibition of SERT. Taurine 156-163 myeloperoxidase Homo sapiens 143-146 21749327-6 2011 Thus we studied the inhibition of MPO-mediated taurine chlorination by tempol at pH 7.4 and re-determined the kinetic constants of the reactions of tempol with MPO-I (k=3.5x105 M-1 s-1) and MPO-II, the kinetics of which indicated a binding interaction (K=2.0x10-5 M; k=3.6x10-2 s-1). Taurine 47-54 myeloperoxidase Homo sapiens 34-37 21090682-4 2010 In vitro assays were used to study the effects of these compounds on the inhibition of MPO-mediated taurine chlorination and oxidation of LDLs. Taurine 100-107 myeloperoxidase Homo sapiens 87-90 20083360-9 2010 While taurine can function as an antioxidant for myeloperoxidase-derived radicals, its positive inotropic effect on the failing heart seems more likely to reflect an effect on intracellular calcium dynamics. Taurine 6-13 myeloperoxidase Homo sapiens 49-64 19239157-5 2009 Taurine supplementation significantly attenuated the severity of diarrhea, colon shortening, histological score, MPO activity elevation and abnormal MIP-2 gene expression, indicating that taurine prevents DSS-induced colitis. Taurine 0-7 myeloperoxidase Homo sapiens 113-116 19239178-2 2009 The reaction between taurine and HOCl, a toxic product of the myeloperoxidase (MPO) system, generates a more stable and less toxic product, taurine chloramine (TauCl). Taurine 21-28 myeloperoxidase Homo sapiens 62-77 19239178-2 2009 The reaction between taurine and HOCl, a toxic product of the myeloperoxidase (MPO) system, generates a more stable and less toxic product, taurine chloramine (TauCl). Taurine 21-28 myeloperoxidase Homo sapiens 79-82 19239157-5 2009 Taurine supplementation significantly attenuated the severity of diarrhea, colon shortening, histological score, MPO activity elevation and abnormal MIP-2 gene expression, indicating that taurine prevents DSS-induced colitis. Taurine 188-195 myeloperoxidase Homo sapiens 113-116 17868637-0 2007 Myeloperoxidase-catalyzed taurine chlorination: initial versus equilibrium rate. Taurine 26-33 myeloperoxidase Homo sapiens 0-15 17619120-4 2008 Taurine supplementation significantly attenuated the weight decrease, diarrhea severity, colon shortening, and the increase in the colonic tissue myeloperoxidase activity induced by DSS. Taurine 0-7 myeloperoxidase Homo sapiens 146-161 18819272-4 2008 The inhibitor of myeloperoxidase NaN3, the HOCl scavengers taurine and methionine, and guaiacol, a substrate for peroxidation cycle of myeloperoxidase, prevented luminescence. Taurine 59-66 myeloperoxidase Homo sapiens 17-32 15893945-7 2005 Similarly, taurine, a scavenger of MPO-generated HOCl, enhanced iNOS induction in MPO-positive cells, but not in MPO-KO cells. Taurine 11-18 myeloperoxidase Homo sapiens 35-38 16732739-5 2006 The formation of lysophospholipids as well as of bromohydrins was not observed when the enzyme or one of its substrates (H2O2 or Br-) was absent from the incubation medium, or if an inhibitor of MPO (sodium azide) or hypobromite scavengers (taurine or methionine) were added. Taurine 241-248 myeloperoxidase Homo sapiens 195-198 16918386-16 2006 The inside of mechanism reveals toxic substance HOCl is produced by MPO is converted to less toxic substances through scavenging action of taurine. Taurine 139-146 myeloperoxidase Homo sapiens 68-71 16274882-5 2005 The chlorination activity of myeloperoxidase was measured by trapping hypochlorous acid with taurine and subsequently using iodide to promote the oxidation reactions of the accumulated taurine chloramine. Taurine 93-100 myeloperoxidase Homo sapiens 29-44 16027960-5 2005 Incubation with taurine resulted in lower intracellular pyruvate and alpha-ketobutyrate levels, decreased O2- and H2O2 formation and a concomitant significantly increased MPO activity. Taurine 16-23 myeloperoxidase Homo sapiens 171-174 15893945-7 2005 Similarly, taurine, a scavenger of MPO-generated HOCl, enhanced iNOS induction in MPO-positive cells, but not in MPO-KO cells. Taurine 11-18 myeloperoxidase Homo sapiens 82-85 15893945-7 2005 Similarly, taurine, a scavenger of MPO-generated HOCl, enhanced iNOS induction in MPO-positive cells, but not in MPO-KO cells. Taurine 11-18 myeloperoxidase Homo sapiens 82-85 15607576-9 2005 An alternative or additional possibility is that the relatively poor taurine status of vegetarians up-regulates the physiological role of myeloperoxidase-derived oxidants in the generation of AGEs - in which case, taurine supplementation might be expected to suppress elevated AGE production in vegetarians. Taurine 214-221 myeloperoxidase Homo sapiens 138-153 14992270-5 2004 One possibility is that taurine reacts with HOCl, produced by the myeloperoxidase (MPO) pathway, to produce the more stable but less toxic taurine chloramine (Tau-Cl). Taurine 24-31 myeloperoxidase Homo sapiens 66-81 15118255-5 2004 Thirdly, while it is well known that taurine scavenges hypochlorous acid (HOCl) produced by myeloperoxidase in neutrophils and macrophages, recent studies revealed that HOCl was one of the major factors oxidizing LDL, implying that the anti-oxidative role of taurine contributes to the anti-atherosclerotic effect. Taurine 37-44 myeloperoxidase Homo sapiens 92-107 15288359-9 2004 In light of recent epidemiological evidence that increased expression of myeloperoxidase - the enzyme which generates HOCL--is an important risk factor for coronary disease, supplemental taurine may indeed have broader utility for suppressing both the genesis and the rupture of atherosclerotic plaque. Taurine 187-194 myeloperoxidase Homo sapiens 73-88 14992270-5 2004 One possibility is that taurine reacts with HOCl, produced by the myeloperoxidase (MPO) pathway, to produce the more stable but less toxic taurine chloramine (Tau-Cl). Taurine 24-31 myeloperoxidase Homo sapiens 83-86 14992270-5 2004 One possibility is that taurine reacts with HOCl, produced by the myeloperoxidase (MPO) pathway, to produce the more stable but less toxic taurine chloramine (Tau-Cl). Taurine 139-146 myeloperoxidase Homo sapiens 66-81 14992270-5 2004 One possibility is that taurine reacts with HOCl, produced by the myeloperoxidase (MPO) pathway, to produce the more stable but less toxic taurine chloramine (Tau-Cl). Taurine 139-146 myeloperoxidase Homo sapiens 83-86 14556977-7 2003 In this paper we have focused on the role of taurine chloramine (TauCl), the physiological product of neutrophil MPO-halide system, in the regulation of immune system. Taurine 45-52 myeloperoxidase Homo sapiens 113-116